Using synthetic biology and AI to address global antimicrobial resistance threat
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.
BoltzGen generates protein binders for any biological target from scratch, expanding AI’s reach from understanding biology toward engineering it.
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
The molecules trigger a built-in cellular stress response and show promise as broad-spectrum antivirals against Zika, herpes, RSV, and more.
In an analysis of over 160,000 transplant candidates, researchers found that race is linked to how likely an organ offer is to be accepted on behalf of a patient.
The framework helps clinicians choose phrases that more accurately reflect the likelihood that certain conditions are present in X-rays.
Annual award honors early-career researchers for creativity, innovation, and research accomplishments.
A deep neural network called CHAIS may soon replace invasive procedures like catheterization as the new gold standard for monitoring heart health.
Starting with a single frame in a simulation, a new system uses generative AI to emulate the dynamics of molecules, connecting static molecular structures and developing blurry pictures into videos.
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
Five MIT faculty and staff, along with 19 additional alumni, are honored for electrical engineering and computer science advances.
With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.